Cargando…
CONDISOX- continued versus discontinued oxytocin stimulation of induced labour in a double-blind randomised controlled trial
BACKGROUND: Oxytocin is an effective drug for induction of labour, but is associated with serious adverse effects of which uterine tachysystole, fetal distress and the need of immediate delivery are the most common. Discontinuation of oxytocin once the active phase of labour is established could red...
Autores principales: | Boie, Sidsel, Glavind, Julie, Uldbjerg, Niels, Bakker, Jannet J. H., van der Post, Joris A. M., Steer, Philip J., Bor, Pinar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720847/ https://www.ncbi.nlm.nih.gov/pubmed/31477047 http://dx.doi.org/10.1186/s12884-019-2461-x |
Ejemplares similares
-
Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial
por: Boie, Sidsel, et al.
Publicado: (2021) -
Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial
Publicado: (2021) -
The Childbirth Experience Questionnaire (CEQ)—Validation of its use in a Danish-speaking population of new mothers stimulated with oxytocin during labour
por: Boie, Sidsel, et al.
Publicado: (2020) -
Induction of labour at 39 weeks versus expectant management in low-risk obese women: study protocol for a randomised controlled study
por: Krogh, Lise Qvirin, et al.
Publicado: (2022) -
Perinatal outcomes after therapeutic rest in the latent phase of labor: A cohort study
por: Bagger, Nanna T., et al.
Publicado: (2023)